<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">therapeutic</journal-id><journal-title-group><journal-title xml:lang="ru">Южно-Российский журнал терапевтической практики</journal-title><trans-title-group xml:lang="en"><trans-title>South Russian Journal of Therapeutic Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8156</issn><publisher><publisher-name>РостГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2712-8156-2021-2-1-102-109</article-id><article-id custom-type="elpub" pub-id-type="custom">therapeutic-129</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Исследование факторов, влияющих на формирование гуморального иммунитета к коронавирусу SARS-COV-2 у студентов-медиков и врачей республики Крым в активную фазу пандемии COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of the factors affecting the formation of humoral immunity to the SARS-COV-2 coronavirus in medical students and doctors of the Republic of Crimea during active phase of the COVID-19 pandemia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1309-4005</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кубышкин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kubyshkin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кубышкин Анатолий Владимирович - доктор медицинских наук, проф., проректор по научной деятельности, заведующий кафедрой общей и клинической патофизиологии Медицинской академии им. С.И. Георгиевского.</p><p>Симферополь</p></bio><bio xml:lang="en"><p>Anatoliy V. Kubyshkin, Dr. Sci. (Med.), Prof., S.I. Georgievsky Medical Academy (structural division).</p><p>Simferopol</p></bio><email xlink:type="simple">kubyshkin_av@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3065-5748</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомочкина</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Fomochkina</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фомочкина Ирина Ивановна - доктор медицинских наук, проф., заместитель директора по научной работе, заведующий кафедрой фармакологии Медицинской академии имени С. И. Георгиевского.</p><p>Симферополь</p></bio><bio xml:lang="en"><p>Irina I. Fomochkina, Dr. Sci. (Med.), Prof., S.I. Georgievsky Medical Academy (structural division).</p><p>Simferopol</p></bio><email xlink:type="simple">fomochkina_i@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5754-4418</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крутиков</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Krutikov</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Крутиков Евгений Сергеевич - доктор медицинских наук, проф., директор Медицинской академии имени С. И. Георгиевского ФГАОУ ВО КФУ им. В.И. Вернадского, заведующий кафедрой пропедевтики внутренней медицины Медицинской академии имени С.И. Георгиевского ВО КФУ им. В.И. Вернадского.</p><p>Симферополь</p></bio><bio xml:lang="en"><p>Evgeniy S. Krutikov, Dr. Sci. (Med.), Prof., S.I. Georgievsky Medical Academy (structural division).</p><p>Simferopol</p></bio><email xlink:type="simple">nephrostar@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3154-3203</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сатаева</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Sataieva</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сатаева Татьяна Павловна – доктор медицинских наук, доцент кафедры медицинской биологии Медицинской академии им. С.И. Георгиевского.</p><p>Симферополь</p></bio><bio xml:lang="en"><p>Tatiana P. Sataieva, Dr. Sci. (Med.), Associated Prof., S.I. Georgievsky Medical Academy (structural division).</p><p>Simferopol</p></bio><email xlink:type="simple">tanzcool@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3770-2965</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агеева</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ageeva</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Агеева Елизавета Сергеевна - заведующий кафедрой биологии медицинской Медицинской академии им. С.И. Георгиевского.</p><p>Симферополь</p></bio><bio xml:lang="en"><p>Elizaveta S. Ageeva, S.I. Georgievsky Medical Academy (structural division).</p><p>Simferopol</p></bio><email xlink:type="simple">ageevaeliz@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6243-3360</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарова</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharova</surname><given-names>А. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Захарова Анна Николаевна - кандидат медицинских наук, доцент преподаватель кафедры судебной медицины Медицинской академии имени С.И. Георгиевского.</p><p>Симферополь</p></bio><bio xml:lang="en"><p>Anna N. Zakharova, Cand. Sci. (Med.), Associated Prof., S.I. Georgievsky Medical Academy (structural division).</p><p>Simferopol</p></bio><email xlink:type="simple">ylyan4ik@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Медицинская академия имени С.И. Георгиевского (структурное подразделение)<country>Россия</country></aff><aff xml:lang="en">S.I. Georgievsky Medical Academy (structural division) of V.I. Vernadsky Crimean Federal University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>24</day><month>03</month><year>2021</year></pub-date><volume>2</volume><issue>1</issue><fpage>102</fpage><lpage>108</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кубышкин А.В., Фомочкина И.И., Крутиков Е.С., Сатаева Т.П., Агеева Е.С., Захарова А.Н., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Кубышкин А.В., Фомочкина И.И., Крутиков Е.С., Сатаева Т.П., Агеева Е.С., Захарова А.Н.</copyright-holder><copyright-holder xml:lang="en">Kubyshkin A.V., Fomochkina I.I., Krutikov E.S., Sataieva T.P., Ageeva E.S., Zakharova А.N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.therapeutic-j.ru/jour/article/view/129">https://www.therapeutic-j.ru/jour/article/view/129</self-uri><abstract><sec><title>Цель</title><p>Цель: изучение факторов, влияющих на показатели гуморального иммунитета у студентов-медиков и врачей города Симферополя путем анкетирования и серологического тестирования. Полученные данные могут свидетельствовать о довольно высокой вовлеченности студентов медицинских вузов и медработников в процессы формирования популяционного иммунитета к COVID-19.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: в период с 14.09.20 по 06.10.20 в Центральной научно-исследовательской лаборатории Медицинской академии имени С.И. Георгиевского методом иммуноферментного анализа с целью выявления сывороточных антител IgG к коронавирусу SARS-CoV-2 были обследованы 67 студентов, а также 19 врачей и медсестер, проживающих в Республике Крым. Все обследуемые лица прошли онлайн-анкетирование.</p></sec><sec><title>Результаты</title><p>Результаты: по данным ИФА (иммуноферментного анализа), антитела к GoV-19 были выявлены у 14 студентов (20,9% [18,3%; 25,1%]), а также у 6 медработников (31,6% [28,9%; 34,2%]) от общего числа обследуемых. Проведенное анкетирование выявило ряд неблагоприятных факторов, способствующих истощению иммунных резервов организма как у студентов, так и у медицинских работников.</p></sec><sec><title>Заключение</title><p>Заключение: исследования серопревалентности к коронавирусу SARS-CoV-2 в различных группах населения, а также механизмов и особенностей сероконверсии, кинетики иммунного ответа и напряжённости гуморального иммунитета играют чрезвычайно важную роль в формировании стратегии и тактики противоэпидемических мероприятий, а в будущем — вакцинопрофилактики COVID-19.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: to study the factors that affect the indicators of humoral immunity in medical students and doctors of the city of Simferopol by means of questionnaires and serological testing. The data obtained may indicate a fairly high involvement of medical students and medical workers in the processes of formation of population immunity to COVID-19.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: from 14.09.20 to 06.10.20 the 67 students, as well as 19 doctors and nurses living in the Republic of Crimea have been examined by the method of enzyme immunoassay to detect IgG serum antibodies to the SARS-CoV-2 coronavirus. All the examined subjects completed the online questionnaire.</p></sec><sec><title>Results</title><p>Results: According to the ELISA the antibodies to CoV-19 were detected in 14 students (20,9% [18,3%; 25,1%]), as well as in 6 health workers (31,6% [28,9%; 34,2%]) of the total examined number. The survey revealed a number of adverse factors that contribute to the depletion of the body's immune reserves in both students and medical professionals.</p></sec><sec><title>Conclusion</title><p>Conclusion: the studies of the seroprevalence to the SARS-CoV-2 coronavirus in various population groups, as well as the mechanisms and features of seroconversion, the kinetics of the immune response and the intensity of humoral immunity may possess an extremely important role in developing the strategy and tactics of antipandemic measures and in the future COVID-19 vaccine prophylaxis.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>коронавирус</kwd><kwd>антитела</kwd><kwd>студенты</kwd><kwd>анкетирование</kwd><kwd>коллективный иммунитет</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronavirus</kwd><kwd>antibodies</kwd><kwd>students</kwd><kwd>questionnaire survey</kwd><kwd>collective immunity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: 10.1056/NEJ-Moa2001017.</mixed-citation><mixed-citation xml:lang="en">Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: 10.1056/NEJ-Moa2001017.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kannan S, Shaik Syed Ali P, Sheeza A, Hemalatha K. COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4):2006-2011. doi: 10.26355/eur-rev_202002_20378.</mixed-citation><mixed-citation xml:lang="en">Kannan S, Shaik Syed Ali P, Sheeza A, Hemalatha K. COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4):2006-2011. doi: 10.26355/eur-rev_202002_20378.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: A brief perspective from the front line. J Infect. 2020;80(4):373-377. doi: 10.1016/j.jinf.2020.02.010.</mixed-citation><mixed-citation xml:lang="en">Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: A brief perspective from the front line. J Infect. 2020;80(4):373-377. doi: 10.1016/j.jinf.2020.02.010.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">4. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.</mixed-citation><mixed-citation xml:lang="en">4. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ioannidis J. The infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021;99:19-33F. doi: 10.2471/BLT.20.265892</mixed-citation><mixed-citation xml:lang="en">Ioannidis J. The infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021;99:19-33F. doi: 10.2471/BLT.20.265892</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pollan M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, Hernan MA, Perez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroep-idemiological study. The Lancet. 2020;396(10250):535-544. DOI: 10.1016/S0140-6736(20)31483-5</mixed-citation><mixed-citation xml:lang="en">Pollan M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, Hernan MA, Perez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroep-idemiological study. The Lancet. 2020;396(10250):535-544. DOI: 10.1016/S0140-6736(20)31483-5</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sekine T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, Gorin JB, Olsson A, et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017.</mixed-citation><mixed-citation xml:lang="en">Sekine T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, Gorin JB, Olsson A, et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Faustini SE, Jossi SE, Perez-Toledo M, Shields A, Allen JD, Wata-nabe Y, et al. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection. medRxiv [Preprint]. 2020:2020.06.16.20133025. doi: 10.1101/2020.06.16.20133025.</mixed-citation><mixed-citation xml:lang="en">Faustini SE, Jossi SE, Perez-Toledo M, Shields A, Allen JD, Wata-nabe Y, et al. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection. medRxiv [Preprint]. 2020:2020.06.16.20133025. doi: 10.1101/2020.06.16.20133025.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sungnak W, Huang N, Becavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681-687. doi: 10.1038/s41591-020-0868-6.</mixed-citation><mixed-citation xml:lang="en">Sungnak W, Huang N, Becavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681-687. doi: 10.1038/s41591-020-0868-6.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou P, et al. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020;17(7):773-775. doi: 10.1038/s41423-020-0474-z.</mixed-citation><mixed-citation xml:lang="en">Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou P, et al. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020;17(7):773-775. doi: 10.1038/s41423-020-0474-z.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
